About
Profile
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire Medical Systems’ proprietary Inspire therapy is the first and only
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
INSP
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Inspire Medical Systems GAAP EPS of -$0.29 beats by $0.27, revenue of $153.3M misses by $1.24M
- Inspire Medical Systems Q3 2023 Earnings Preview
- UBS’s top crowded longs and shorts in MedTech
- Inspire Medical Systems GAAP EPS of -$0.41 beats by $0.17, revenue of $151.1M beats by $14.61M
- Inspire Medical Systems Q2 2023 Earnings Preview
- Inspire Medical wins FDA expanded labeling for sleep apnea device
- Inspire Medical Systems Q1 results beat estimates, co raises FY 2023 revenue guidance
- Inspire Medical Systems Q1 2023 Earnings Preview
- Inspire Medical gets FDA nod for Inspire therapy's use in children with down syndrome
- Inspire Medical Systems GAAP EPS of $0.10 beats by $0.68, revenue of $137.9M beats by $0.15M
- Inspire Medical Systems Q4 2022 Earnings Preview
- Inspire Medical stock rises after guiding revenue above estimates
- Inspire Medical nears eight-month high as KeyBanc issues bullish call
- Inspire Medical Systems GAAP EPS of -$0.60 beats by $0.16, revenue of $109.2M beats by $14.59M
- Inspire Medical Systems Q3 2022 Earnings Preview
- Inspire Medical Systems prices 1M of stock offering at $215.00/share
- Inspire Medical Systems launches offering of 1M shares
- Inspire Medical Systems GAAP EPS of -$0.53 beats by $0.07, revenue of $91.4M beats by $13.34M
- Inspire Medical Systems Q2 2022 Earnings Preview
- Inspire Medical gets FDA nod for full-body MRI compatibility with Inspire therapy
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| After hrs | 233.77 | 0% | ||||||||
| Feb 15, 2022 | 233.77 | 229.83 |
235.66
|
227.52
|
235.02K | 3.93% | ||||
| Feb 14, 2022 | 224.92 | 226.38 |
231.17
|
222.19
|
236.36K | -1.15% | ||||
| Feb 11, 2022 | 227.53 | 236.32 |
239.54
|
223.59
|
235.75K | -3.1% | ||||
| Feb 10, 2022 | 234.81 | 229.53 |
240.51
|
225.00
|
282.24K | -1.5% | ||||
| Feb 9, 2022 | 238.38 | 240.00 |
246.25
|
230.40
|
619.66K | 2% | ||||
| Feb 8, 2022 | 233.71 | 224.56 |
236.89
|
224.56
|
416.89K | 3.32% | ||||
| Feb 7, 2022 | 226.21 | 222.38 |
232.79
|
222.38
|
376.15K | 1.44% | ||||
| Feb 4, 2022 | 223.00 | 211.38 |
226.43
|
209.88
|
310.43K | 4.64% | ||||
| Feb 3, 2022 | 213.12 | 214.72 |
219.43
|
212.13
|
222.71K | -2.91% | ||||
| Feb 2, 2022 | 219.50 | 221.96 |
223.88
|
216.02
|
242.42K | -1.43% | ||||
| Feb 1, 2022 | 222.69 | 222.52 |
227.12
|
218.34
|
306.85K | 0.63% | ||||
| Jan 31, 2022 | 221.29 | 208.95 |
223.97
|
207.93
|
314.29K | 6.39% | ||||
| Jan 28, 2022 | 208.00 | 196.58 |
208.78
|
189.24
|
292.16K | 6.58% | ||||
| Jan 27, 2022 | 195.16 | 201.50 |
204.53
|
193.91
|
251.67K | -1.45% | ||||
| Jan 26, 2022 | 198.03 | 198.93 |
206.94
|
194.60
|
386.50K | 2.11% | ||||
| Jan 25, 2022 | 193.94 | 204.33 |
207.27
|
191.16
|
423.97K | -7.88% | ||||
| Jan 24, 2022 | 210.52 | 202.18 |
211.48
|
192.00
|
384.37K | 1.86% | ||||
| Jan 21, 2022 | 206.68 | 210.59 |
212.51
|
204.03
|
220.23K | -2.59% | ||||
| Jan 20, 2022 | 212.18 | 219.62 |
226.67
|
211.31
|
175.17K | -2.01% | ||||
| Jan 19, 2022 | 216.54 | 220.95 |
225.06
|
212.95
|
191.83K | -1.99% | ||||
| Jan 18, 2022 | 220.93 | 233.94 |
236.43
|
220.92
|
385.55K | -6.99% | ||||